" class="no-js "lang="en-US"> Jeff Albers - Medtech Alert
Friday, March 29, 2024
Jeff Albers

Jeff Albers

About Jeff Albers

Joint business and legal background with experience as a life sciences corporate attorney prior to executive roles in commercial and business development. Diverse commercial experience across sales, marketing, managed markets, and operations.

Related Story

Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics

November 29 2021

Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that the company has entered into a definitive agreement […]